Search research articles
Contact Us
Filters
Showing results (241-250 of 352) with videos related to
Page
of 36
Sort By:
Plos Genetics
|
March 7, 2012
Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease
Maureen J Koslowski, Zora Teltschik, Julia Beisner, et al.
Journal of Crohn'S & Colitis
|
June 17, 2026
Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results
Vipul Jairath, Fernando Magro, Marijana Protic, et al.
Gastroenterology
|
February 14, 2012
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial
Paul Rutgeerts, Gert Van Assche, William J Sandborn, et al.
Journal of Crohn'S & Colitis
|
July 22, 2025
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review
Sophie Vieujean, Bruce E Sands, Remo Panaccione, et al.
Journal of Crohn'S & Colitis
|
January 2, 2016
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
William J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, et al.
Plos One
|
March 26, 2013
A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease
Satish Keshav, Tomáš Vaňásek, Yaron Niv, et al.
Inflammatory Bowel Diseases
|
January 13, 2015
Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC
Guillaume Bouguen, Charles Sninsky, Kezhen L Tang, et al.
Inflammatory Bowel Diseases
|
November 9, 2025
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review
David T Rubin, Walter Reinisch, Neeraj Narula, et al.
Journal of Crohn'S & Colitis
|
July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme
Stefan Schreiber, David T Rubin, Siew C Ng, et al.
Journal of Crohn'S & Colitis
|
April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspective
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Page
of 36
Search research articles
Search
Showing results (241-250 of 352) with videos related to
Sort By:
Page
of 36
Plos Genetics
|
March 7, 2012
Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease
Maureen J Koslowski, Zora Teltschik, Julia Beisner, et al.
Journal of Crohn'S & Colitis
|
June 17, 2026
Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results
Vipul Jairath, Fernando Magro, Marijana Protic, et al.
Gastroenterology
|
February 14, 2012
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial
Paul Rutgeerts, Gert Van Assche, William J Sandborn, et al.
Journal of Crohn'S & Colitis
|
July 22, 2025
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review
Sophie Vieujean, Bruce E Sands, Remo Panaccione, et al.
Journal of Crohn'S & Colitis
|
January 2, 2016
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
William J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, et al.
Plos One
|
March 26, 2013
A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease
Satish Keshav, Tomáš Vaňásek, Yaron Niv, et al.
Inflammatory Bowel Diseases
|
January 13, 2015
Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC
Guillaume Bouguen, Charles Sninsky, Kezhen L Tang, et al.
Inflammatory Bowel Diseases
|
November 9, 2025
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review
David T Rubin, Walter Reinisch, Neeraj Narula, et al.
Journal of Crohn'S & Colitis
|
July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme
Stefan Schreiber, David T Rubin, Siew C Ng, et al.
Journal of Crohn'S & Colitis
|
April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspective
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Page
of 36